Announcements Trials

Browse Landscape

Phase

Status

Recruiting 3 Completed 2 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Plasma cell 1 Other hematologic neoplasm 1 Lymphoid 1 Head & Neck 1 Gastrointestinal 1 Breast 1

Conditions

Lung Neoplasms 1

Interventions

Carboplatin 134 pembrolizumab 113 Pemetrexed 94 Cisplatin 88 durvalumab 62 Paclitaxel 60 osimertinib 54 Nivolumab 54 Docetaxel 44 atezolizumab 41 Etoposide 30 Radiotherapy 28 Radiosurgery 26 Gemcitabine 26 Specimen Handling 24 Ipilimumab 23 Taxes 19 Magnetic Resonance Spectroscopy 19 amivantamab 16 130-nm albumin-bound paclitaxel 16 Drug Therapy 15 Bevacizumab 15 Radiation 14 Platinum 14 Immunoglobulin G 14 Disulfides 14 cemiplimab 13 Crizotinib 13 Cyclophosphamide 12 Biopsy 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Mass Screening × Thoracic × Clear all

NCT02247453 2024-03-07

BIOMILD

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase NA Active not recruiting

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡